title: Survival Rates for Breast Cancer in Iranian Patients: a Meta- Analysis.
abstract: BACKGROUND
  Breast cancer is the most common cancer among Iranian women. Since development of the disease in Iranian women occurs relatively early, the survival rate matters considerably. In different countries, survival of breast cancer patients varies considerably. Therefore, the one-year, three-year, five-year, and ten- year survival rates for breast cancer in Iran were assessed using a meta-analysis.
  
  
  METHODS
  This systematic review and meta-analysis was based on valid Iranian sources including SID, MAGIRAN and IRANMEDEX, along with reliable English databases, namely, PUBMED and SCOPUS. In domestic databases, a search was conducted based on key words of breast cancer and survival rate, and in international databases, with "breast cancer" and the equivalent of "neoplasm" of Mesh Word, "survival rate" and "Iran. " Then all reviewed papers and theses which met the inclusion criteria were selected for investigation. To conduct the analysis STATA 11.2 software and random-effects models were used.
  
  
  RESULTS
  In 24 studies, 22,745 participants were included. The one-year, three-year, five-year and ten-year survival rates were 0.956, 0.808, 0.695 and 0.559, respectively. The minimum and maximum survival rates for 5-years were 0.48 and 0.87. The average age of the onset of the disease was 48.3.
  
  
  CONCLUSIONS
  As in Iran, since the onset of the disease is at low age, in spite of the relatively high survival rate as compared to other cancers, prevention and screening programs at early age for early stage diagnosis seems necessary.
authors.affiliation: affiliation E-mail : email.
authors.forename: Mitra
authors.initials: M
authors.lastname: Rahimzadeh
authors.forename: Mohamad Amin
authors.initials: MA
authors.lastname: Pourhoseingholi
authors.forename: Behrooz
authors.initials: B
authors.lastname: Kavehie
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology* / Q000401:mortality*; D005260:Female; D006801:Humans; D015995:Prevalence; D011379:Prognosis; D015996:Survival Rate